# National Assembly Forum Explores Future of Hops-Derived CBD Industry > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/national-assembly-forum-explores-future-of-hops-derived-cbd-industry/ > **Published:** 2026-06-20T17:09:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-08T20:22:02-04:00 > **Clinical Summary:** Hops-derived CBD offers regulatory alternatives for patient access. Clinically identical to cannabis CBD, but quality standards vary. What clinicians need to know. --- ✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. CBDHempIndustryPolicyResearchPainSafety Clinical Summary This article discusses emerging opportunities in the hops-derived cannabidiol (CBD) industry, which represents an alternative source for CBD production outside traditional [cannabis cultivation](https://cedclinic.com/growing-medical-marijuana-at-home-guide/). Hops-derived CBD offers potential regulatory and supply chain advantages since it circumvents cannabis scheduling restrictions in certain jurisdictions, potentially expanding access to [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) for patients seeking anti-inflammatory and analgesic effects. The non-cannabis origin of this CBD may facilitate more consistent product standardization, quality control, and pharmaceutical development pathways compared to plant-derived cannabis products. For clinicians, this development could mean greater availability of standardized, regulated CBD formulations with predictable dosing and efficacy profiles for patients with [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) and inflammatory conditions. The practical implication for clinical practice is that hops-derived CBD may eventually provide a more accessible and medically vetted alternative to traditional cannabis-derived products, though efficacy and safety profiles will require robust comparative [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) to establish equivalence. Dr. Caplan’s Take “The early signals around hops-derived cannabinoids are worth watching from a pharmacological standpoint, but we’re still in the preliminary stages with limited human clinical data, so I’m cautious about making therapeutic claims until we have properly conducted trials comparing efficacy and safety profiles to established treatments.” Clinical Perspective 🌿 The emergence of hops-derived cannabidiol as a non-cannabis source of CBD presents an intriguing regulatory and therapeutic pathway, though clinicians should exercise caution before drawing premature conclusions about its efficacy or safety profile. While the distinction between hops-derived and cannabis-derived CBD may offer regulatory advantages and broader market accessibility, the pharmacological equivalence of these sources remains incompletely characterized, and claims regarding pain and inflammation reduction require rigorous clinical validation rather than reliance on preliminary industry-sponsored assessments. Key confounders include variation in extraction methods, purity standards, and the absence of standardized dosing protocols that currently plague the broader CBD marketplace. Clinicians encountering patients interested in [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) should remain informed about these emerging alternatives while maintaining evidence-based skepticism, counseling patients that robust clinical trial data supporting CBD efficacy for [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) or inflammation is still limited and that regulatory status does not equate to proven therapeutic 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20National%20Assembly%20Forum%20Explores%20Future%20of%20Hops-Derived%20CBD%20Industry%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D60981)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D60981)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20National%20Assembly%20Forum%20Explores%20Future%20of%20Hops-Derived%20CBD%20Industry%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D60981)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://en.sedaily.com/society/2026/06/20/national-assembly-forum-explores-future-of-hops-derived-cbd](https://en.sedaily.com/society/2026/06/20/national-assembly-forum-explores-future-of-hops-derived-cbd) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).